BB Biotech Joins SPI ESG Index

BB Biotech AG has announced its inclusion in the SPI ESG Index of the SIX Swiss Exchange, effective September 22, 2025. This inclusion reflects the company's dedication to responsible investing and sustainable corporate governance. Dr. Christian Koch, Head of BB Biotech at Bellevue Asset Management, emphasized that this milestone affirms their focus on biotechnology firms that deliver both financial value and societal benefits.

The SPI ESG Index, launched in 2021, comprises companies from the Swiss Performance Index selected based on stringent criteria by sustainability agency Inrate. This index serves as a transparent benchmark for sustainable investments in Switzerland, increasing BB Biotech’s appeal among ESG-focused investors and reinforcing the long-term value of its portfolio.